This inventor holds 2 USPTO granted patents. Top assignees: Center for Disease Control and Prevention, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1999-2004.
Company Filing History:

Years Active: 1999-2004
Title: Paul A. Sandstrom: Innovator in Retrovirology
Introduction
Paul A. Sandstrom is a notable inventor based in Decatur, GA (US), recognized for his contributions to the field of retrovirology. With a total of 2 patents, Sandstrom has made significant strides in understanding and isolating human retroviruses, particularly spumaviruses.
Latest Patents
Sandstrom's latest patents include groundbreaking work on the isolation of a human retrovirus. The first patent details compositions and methods involving a spumavirus isolated from a human who had exposure to nonhuman primates. This invention is crucial as it provides methods and compositions that can detect the presence of spumavirus or antibodies in body fluids. Additionally, it has applications in pathogenicity studies of related viruses and serves as a vector for gene therapies. The second patent also focuses on a retrovirus isolated from humans, emphasizing similar applications for detection and treatment of conditions related to rapidly dividing cells.
Career Highlights
Throughout his career, Paul A. Sandstrom has worked with esteemed organizations such as the Centers for Disease Control and Prevention and the United States Department of Health and Human Services. His work in these institutions has allowed him to contribute significantly to public health and virology research.
Collaborations
Sandstrom has collaborated with notable colleagues, including Thomas M. Folks and Walid M. Heneine, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Paul A. Sandstrom's innovative work in retrovirology has paved the way for advancements in the detection and treatment of viral infections. His contributions continue to influence the field and improve public health outcomes.